X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

International Immunopharmacology

期刊標題檢索 INT IMMUNOPHARM 最新評論: How much time was given for the modification? (2024-10-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[International Immunopharmacology]您好,您是該頁面的第 339372 位訪客。

期刊簡介
期刊名稱International Immunopharmacology International Immunopharmacology
LetPub Score
7.4
50 ratings
Rate

Reputation
8.0

Influence
6.6

Speed
8.8

期刊簡稱INT IMMUNOPHARMACOL
ISSN1567-5769
E-ISSN1878-1705
h-index98
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.401.1670.946
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q160 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy
Q261 / 233
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology
Q272 / 236

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
官方網站https://www.journals.elsevier.com/international-immunopharmacology
在線稿件提交https://www.editorialmanager.com/INTIMP
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率月刊
創刊年2001
每年文章數1554每年文章數趨勢
黃金OA百分比14.48%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ251/181
PHARMACOLOGY & PHARMACYSCIEQ150/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.7 month(s)
來自Elsevier的數據: Average 7.5 Week(s)
競爭力 *來自作者的數據: About 81.66%
在線文章發布時間來自Elsevier的數據: Average 2.7 Week(s)
參考鏈接
相關期刊 【International Immunopharmacology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF IMMUNOLOGY156821
    Immunity108141
    Cellular & Molecular Immunology107586
    Vaccine104893
    JOURNAL OF EXPERIMENTAL MEDICINE99645
    MICROBIAL PATHOGENESIS94371
    MOLECULAR IMMUNOLOGY91253
    INFLAMMATION89910
    BRAIN BEHAVIOR AND IMMUNITY84944
    IMMUNOLOGY79121
  •  

    International Immunopharmacology International Immunopharmacology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/58)
  [International Immunopharmacology] 的評論撰寫評論
作者: lucky boy-5


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-30 17:17:38 評論於
How much time was given for the modification?
(0) 讚! | lucky boy-5

作者: lucky boy-5


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-30 17:16:38 評論於
How long did it take for your major revision to be edited?
(0) 讚! | lucky boy-5

作者: 谢大头


領域: 医学
審稿時間: 10.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-29 11:01:44 評論於
Received at Editorial Office
28 Jul 2024
Article revised
23 Sep 2024
Article accepted for publication
25 Oct 2024
(0) 讚! | 谢大头

作者: wmomo


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 09:27:39 評論於
Hello, have you found the reviewer later? It has been almost 2 months since I started looking for one, and only one reviewer has agreed to review. How many reviewers are needed in total?
(0) 讚! | wmomo

作者: 上上强度


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-28 17:33:43 評論於
Optional open access.
(0) 讚! | 上上强度

作者: 沃德摩尔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-25 23:58:49 評論於
Is the review process fast?
(0) 讚! | 沃德摩尔

作者: Toby Emmie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 15:14:27 評論於
You can choose non-OA.
(0) 讚! | Toby Emmie

作者: 明冠力勤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-22 22:54:42 評論於
Review speed: 1.0 | Submission hit rate: 95.0 Focus on research directions: Immunology; Inflammation; Clinical experience sharing: The speed is very fast, submitted for review the next day, only minor revisions for cell experiments were accepted, grateful for the kind-hearted editor #Journal Forum#!!! #Journal Forum##Journal Forum##Journal Forum#
(0) 讚! | 明冠力勤

作者: 明冠力勤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-22 10:43:23 評論於
Review speed: 1.0 | Submission hit rate: 95.0 Research focus: Immunology; Inflammation; Clinical experience sharing: Very fast speed, submitted for review the next day, only minor revisions accepted for cell experiments, grateful for the kind-hearted editor!!!
(0) 讚! | 明冠力勤

作者: 8272


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 23:21:30 評論於
Submission must also recommend six reviewers, asking for help from the academicians, where can I find them?
(0) 讚! | 8272

作者: 上清鸿福


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 21:53:18 評論於
What type of article is it?
(0) 讚! | 上清鸿福

作者: 七伤梦玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 17:23:56 評論於
You can choose between OA and non-OA.
(0) 讚! | 七伤梦玉

作者: wmomo


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 10:32:07 評論於
Can't find a reviewer, what should I do? It's been 2 months.
(0) 讚! | wmomo

作者: 一条小卫利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 23:12:54 評論於
I am the same, waiting for the results, feeling anxious.
(0) 讚! | 一条小卫利

作者: 饮香Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 10:19:35 評論於
Even with added validation, the conventional prognostic model is still rejected without hesitation.
(0) 讚! | 饮香Sama

作者: drzhangzz


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-15 09:37:02 評論於
Submitted on July 12, 2024, revised on September 5, 2024, received back after 10 days, submitted for review on October 5, 2024, and accepted a week later. The editor was very kind, a Chinese national, and initially had trouble finding reviewers, so they kept sending me additional invitations every week until finally gathering a panel of 3 reviewers.
(0) 讚! | drzhangzz

作者: 罗宾赫林


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 12:23:26 評論於
Review speed: 2.0 | Submission hit rate: 50.0
Emphasized research direction: Experience sharing of traditional Chinese medicine monomers: 8.8 submissions, invited 61 people from 8-16, 6 accepted, and now 2 have completed. I don't quite understand this speed, the current status is still Required Reviews Completed. Two reviewers have already given feedback so quickly, could it be rejection feedback?
(0) 讚! | 罗宾赫林

作者: 七步俊喆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-04 17:16:28 評論於
Is there a layout fee?
(0) 讚! | 七步俊喆

作者: 柯


領域: 环境科学与生态学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-01 22:20:24 評論於
May I ask how many reviewers the author invited to edit after "Under Review"?
(0) 讚! | 柯

作者: 南风又薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 08:16:49 評論於
Is there a layout fee?
(0) 讚! | 南风又薇

作者: 震雷向文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-20 13:40:15 評論於
The same question.
(0) 讚! | 震雷向文

作者: 进击的乌龟王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-15 19:30:22 評論於
I have to do the same.
(0) 讚! | 进击的乌龟王

作者: ZF17


領域: 医学
審稿時間: 12.0 month(s)
結果: 修改後接受


撰寫評論

2024-09-14 12:58:37 評論於
Hired.
(0) 讚! | ZF17

作者: ZF17


領域: 医学
審稿時間: 12.0 month(s)
結果: 修改後接受


撰寫評論

2024-09-14 12:57:50 評論於
Employment after modification
(0) 讚! | ZF17

作者: 龙象利彬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 08:11:13 評論於
How are you doing? Mine has also been stuck on RRC for a while, urgent urgent urgent.
(0) 讚! | 龙象利彬

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/58)

開始撰寫 [International Immunopharmacology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*